Latest Breaking News On - Mymd pharmaceuticals inc - Page 6 : comparemela.com

MyMD Pharmaceuticals, Inc (NASDAQ:MYMD) Sees Large Growth in Short Interest

MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 3,950,000 shares, a growth of 17.9% from the November 15th total of 3,350,000 shares. Based on an average daily volume of 730,000 shares, […]

Mymd pharmaceuticals incNews ratings for mymd pharmaceuticals dailyYork mellon corpCommonwealth equity servicesRenaissance technologiesMymd pharmaceuticalsMymd pharmaceuticals stock downInstitutional investors weigh in on mymd pharmaceuticalsAtlas brown incGet free reportNew york mellon corpStreet groupStock downNasdaq mymd

Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences (NASDAQ:ATNF), Altisource Asset Mgmt (AMEX:AAMC)

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.

Mymd pharmaceuticals incWuhan sendcloud technology co ltdMymd pharmaceuticalsLifesciences incHoldings limitedNextplay technologies incPetros pharmaceuticalsPetros pharmaceuticals incMuhua information technology co ltdJin medical international ltdShengfeng development limitedWang lee group incAltisource asset management corporationNuburu incGlobal incEdesa biotech inc

Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Shares of ReShape Lifesciences Inc. (NASDAQ:RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approv.

Therapeutics incAltisource asset management corporationLife sciences corpMuhua information technology co ltdPetros pharmaceuticalsAurora mobile limitedWang lee group incHoldings limitedNorthrop grummanNuburu incMymd pharmaceuticals incInnovative international acquisition corpWuhan sendcloud technology co ltdNextplay technologies incGlobal incMobilicom limited

MyMD Pharmaceuticals (MYMD) Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis

MyMD Pharmaceuticals (MYMD) Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesChris chapmanMymd pharmaceuticals incDrug administrationInvestigational new drug

MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis

MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobert schatzChris chapmanImmunex corporationDrug administrationCompany annual report on formMymd pharmaceuticals incInvestigational new drugAnnual report